Sarcoma patients' significant symptom burden negatively impacts quality of life
the ONA take:
Adult patients with sarcoma experience a significant physiological and psychological symptom burden, which has a strong negative impact on health-related quality of life (HRQoL), with numerous physiological symptoms undertreated with medications, a study published in the journal Supportive Care in Cancer has shown.
For the study, researchers evaluated 79 patients with sarcoma in order to evaluate how symptom burden affects HRQoL and medication use. Most patients were diagnosed with stromal tumor, while some had leiomyosarcoma and liposarcoma.
Results showed that the most common physical symptoms experienced by patients were tiredness, lack of energy, and difficulty sleeping, while the most prevalent psychological symptoms were irritability, worrying, and anxiety.
Researchers found that 33.0% of patients reported difficulty sleeping, but only 6.3% of all patients received hypnotics.
Similarly, only 1.3% of all patients received appetite stimulants while 27.9% of patients reported experiencing lack of appetite.
Adult patients with sarcoma experience significant symptom burden, which has a strong negative impact on health-related quality of life.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|